Raclopride, a new selective ligand for the dopamine-D2 receptors.

Prog Neuropsychopharmacol Biol Psychiatry

Research and Development Laboratories, Astra Alab AB, Södertälje, Sweden.

Published: March 1989

1. The use of raclopride, a new compound of the salicylamide series, as a ligand for the labelling of dopamine-D2 receptors in vitro and in vivo is described. 2. 3H-Raclopride has a high affinity for the dopamine-D2 receptors (Kd = 1 nM in rat striatum) with much less affinity for any other receptor. 3. 3H-Raclopride enters the brain easily and has therefore also been used in in vivo binding and autoradiography. The nonspecific binding is very low both in vitro and in vivo. 4. Raclopride has been labelled with 11C, and is used as a marker for dopamine-D2 receptors in the living human brain using positron emission tomography.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0278-5846(88)90001-2DOI Listing

Publication Analysis

Top Keywords

dopamine-d2 receptors
16
vitro vivo
8
raclopride selective
4
selective ligand
4
dopamine-d2
4
ligand dopamine-d2
4
receptors
4
receptors raclopride
4
raclopride compound
4
compound salicylamide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!